<?xml version="1.0" encoding="UTF-8"?>
<p>Unfortunately, these effective interventions are often not available when and where they are needed, largely due to unnecessary legal restrictions. With limited exceptions, only federally certified opioid treatment programs are permitted to dispense methadone for OUD treatment, and federal regulations require that many individuals travel to the clinic most days of the week to obtain their medication. Buprenorphine is also highly regulated. Only providers who have obtained a federal “waiver” may prescribe buprenorphine for OUD treatment, and regulations limit the number of concurrent patients prescribers may treat.
 <sup>
  <xref rid="R7" ref-type="bibr">7</xref>
 </sup> Meanwhile, state laws limit access to sterile syringes, and naloxone's status as a prescription-only medication dramatically limits naloxone access, particularly among uninsured individuals and those without a health care home.
 <sup>
  <xref rid="R8" ref-type="bibr">8</xref>,
  <xref rid="R9" ref-type="bibr">9</xref>
 </sup>
</p>
